Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes
The EXOPULSE Study is a clinical trial/database from Exoneural Network AB to collect routine clinical outcomes for several neurological cond…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Non-invasive Brain Stimulation in Multiple Sclerosis Fatigue [NA]
A Charite University-sponsored study is evaluating non-invasive brain stimulation to treat fatigue in multiple sclerosis and is currently re…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Wearables for the Bladder: an In-home Treatment Feasibility Pilot Study [NA]
A feasibility pilot study evaluating the use of wearables for in-home treatment of bladder symptoms in people with multiple sclerosis and ov…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of Frexalimab (SAR441344) in adults with nonrelapsing secondary progressive multip…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS [NA]
This clinical trial is investigating whether acute intermittent hypoxia can affect neuroplasticity in people with multiple sclerosis. The st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis [Phase 3]
A Phase 3 clinical trial update for IMU-838 in relapsing multiple sclerosis indicates the study is active but not recruiting, with focus on …
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: The Synergistic Effects of AIH and FES in Persons With MS [NA]
This clinical trial update covers a study evaluating the synergistic effects of AIH and Functional Electrical Stimulation (FES) in people wi…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Blood Flow Restriction And Veterans With MS [NA]
A clinical trial is evaluating blood flow restriction as an intervention for veterans with multiple sclerosis and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Relationship Between Pelvic Floor Dysfunctions and Lower Limb Strength and Activation in MS Patients
A clinical trial investigates the relationship between pelvic floor dysfunction and lower limb strength/activation in people with multiple s…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Lead Exposure and Multiple Sclerosis
This update describes a clinical study investigating lead exposure in relation to Multiple Sclerosis, sponsored by Assiut University, which …
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Central Vein Sign in Multiple Sclerosis Extension Study [NA]
A Cleveland Clinic-led clinical trial evaluating the central vein sign in patients with multiple sclerosis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: The Effects of Face-to-face and Tele-nursing Education on Fatigue, Pain, Sleep, and Urinary Tract Infections in Patients With Multiple Sclerosis. [NA]
Clinical trial update describing an ongoing study evaluating the effects of face-to-face and tele-nursing education on fatigue, pain, sleep,…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA)
Clinical trial update describing predictors of level of response to Cladribine tablets in clinical practice for multiple sclerosis (CLODINA)…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab Treatment [Phase 3]
An extension Phase 3 trial update for multiple sclerosis to assess physical function and provide continued treatment with ocrelizumab; the s…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Bright Light Therapy for Sleep Disturbance in People With Multiple Sclerosis [NA]
A completed clinical trial evaluated bright light therapy for sleep disturbances in people with multiple sclerosis.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Multiple Sclerosis Implementation Network (Registry)
This entry describes a clinical trial registry called the Multiple Sclerosis Implementation Network (Registry), sponsored by The University …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Assessment of Trunk Control and Postural Instability in Patients With Various Neurological Disorders (Stroke, Parkinson, Sclerosis Multiplex) Using Objective Tools (TecnoBody ProKin Posturometry, 3D Motion Analysis) [NA]
Clinical trial update evaluating trunk control and postural instability in patients with stroke, Parkinson's disease, and multiple sclerosis…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Periodontal Health Profile in Multiple Sclerosis Patients
This clinical trial update describes a study evaluating periodontal health in people with multiple sclerosis and periodontitis, and it is no…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Mastication, Cognition, and Nutritional Status in Multiple Sclerosis
A clinical trial at Ondokuz Mayıs University is investigating how mastication relates to cognition and nutritional status in people with Mul…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: BrainAgeMS - a Comparative Study of Brain Aging in Healthy and Patients With Multiple Sclerosis
A clinical trial comparing brain aging in healthy individuals and patients with Multiple Sclerosis is currently recruiting in Switzerland (I…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases [EARLY_Phase 1]
This document reports an early-phase (Phase 1) clinical trial of QT-019C UCAR T-cell therapy targeting CD19 and BCMA in relapsed/refractory …
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
A long-term follow-up study for participants previously treated with KYV-101; recruitment is ongoing across multiple autoimmune diseases.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Effect of Sensory Integration Therapy on Gait Variability and Quality Of Life in Patients With Multiple Sclerosis [NA]
This clinical trial is evaluating the effect of sensory integration therapy on gait variability and quality of life in people with Multiple …
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2) [Phase 1]
A Phase 1 study evaluating CC-97540 in relapsing and progressive forms of multiple sclerosis and refractory myasthenia gravis is currently r…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Music-Augmented Rhythmic Gait Training in Multiple Sclerosis [NA]
This entry notes a clinical trial evaluating music-augmented rhythmic gait training for people with multiple sclerosis, and it is currently …